Combo of pancreatic cancer drugs leads to strong response rate
Key Points:
- Revolution Medicines’ experimental pancreatic cancer drug has been the star of the oncology field in recent weeks, with new data showing the medicine produced unprecedented outcomes for patients.
- Its